Federation des caisses Desjardins du Quebec’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	-$470	–	2595
2021 Q1	$470	Hold	7	–	–	﹤0.01%	2399
2020 Q4	$243	Hold	7	–	–	﹤0.01%	2289
2020 Q3	$392	Hold	7	–	–	﹤0.01%	2093
2020 Q2	$269	Hold	7	–	–	﹤0.01%	2061
2020 Q1	$179	Hold	7	–	–	﹤0.01%	2167
2019 Q4	$350	Hold	7	–	–	﹤0.01%	2253
2019 Q3	$353	Hold	7	–	–	﹤0.01%	2219
2019 Q2	$650	Hold	7	–	–	﹤0.01%	2174
2019 Q1	$1.05K	Hold	7	–	–	﹤0.01%	1969
2018 Q4	$1.13K	Hold	7	–	–	﹤0.01%	1952
2018 Q3	$1.75K	Sell	7 -9	-56%	-$2.13K	﹤0.01%	2002
2018 Q2	$3.68K	Sell	16 -20	-56%	-$5.36K	﹤0.01%	1952
2018 Q1	$8.75K	Hold	36	–	–	﹤0.01%	1747
2017 Q4	$11K	Buy	36 +7	+24%	+$2.3K	﹤0.01%	1693
2017 Q3	$10.4K	Buy	+29	New	+$10.3K	﹤0.01%	1666

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DMK Position: Q2 2021 in Review

Federation des caisses Desjardins du Quebec sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2021, closing a stake of 7 shares — an estimated $470 sold.

Federation des caisses Desjardins du Quebec first reported a position in DMK in Q3 2017 and held it in 15 quarters. The position peaked at $11K in Q4 2017. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2021.

Federation des caisses Desjardins du Quebec reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 7 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2021, an estimated $470.
Federation des caisses Desjardins du Quebec first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2017 and held it in 15 quarters.
Federation des caisses Desjardins du Quebec's DMK Pharmaceuticals Corporation Common Stock position peaked at $11K in Q4 2017.
51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2021, filed 30 Aug 2024.